MSF-30298-31989
1 vaccination
1 coded response
3 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 917 / CA
- Registered
- 2021-03-13
- Relationship
- Self
- Race
- N/A
- Ethnicity
- N/A
Timeline
-
2021-03-06
Dose 1 — Pfizer-BioNTech
-
2021-03-13
Registered in v-safe
- 2021-03-13
- 2021-03-20
-
2021-06-05
Survey response — 3 months, dose 1MedDRA: Abortion spontaneous, Uterine dilation and curettage — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Miscarriage leading to suction D & CMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-05
Report sent to call center — 3 months, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-06 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-06-05 | Unsuccessful |
Free text
Release 8 — 3 months, dose 1
Symptoms: Miscarriage leading to suction D & C
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | ✓ | ✓ | ✓ |
| SD | Uterine dilation and curettage | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release